Skip to main content

Variations to Inventory listings after evaluation: CAS 84434-22-0 and 145-39-1

An obligation to provide specific information to AICIS will be added to the terms of listing for musk tibetene and a structural analogue on the Australian Inventory of Industrial Chemicals (Inventory). 

  • Benzene, 3-(1,1-dimethylethyl)-1,5-dimethyl-2,4-dinitro- 
    CAS no. 84434-22-0 
  • Benzene, 1-(1,1-dimethylethyl)-3,4,5-trimethyl-2,6-dinitro- 
    CAS no. 145-39-1 

Reason for varying the Inventory listings 

AICIS completed an evaluation under Part 4 of the Industrial Chemicals Act 2019 (IC Act). AICIS published its final evaluation statement on 22 December 2022, following public consultation. 

For the reasons set out in page 7/paragraph 3 of the evaluation statement, the Executive Director of AICIS concluded that a variation to the Inventory terms of listings of the chemicals is necessary to manage the risks from the introduction of these chemicals. 

Therefore, the Executive Director is varying the terms of listing for these chemicals on the Inventory under section 86 of the IC Act.  The variations will take effect on 8/02/2023

CAS Number  84434-22-0 
Chemical Name  Benzene, 3-(1,1-dimethylethyl)-1,5-dimethyl-2,4-dinitro- 
Molecular Formula  C12H16N2O4 
Specific information requirements as varied 

Obligations to provide information apply. You must tell the Executive Director the volume of introduction, use and end use of the chemical within 20 working days if:  

  • the chemical is being introduced for uses other than research and development 
CAS Number  145-39-1 
Chemical Name  Benzene, 1-(1,1-dimethylethyl)-3,4,5-trimethyl-2,6-dinitro- 
Molecular Formula  C13H18N2O4 
Specific information requirements as varied

Obligations to provide information apply. You must tell the Executive Director the volume of introduction, use and end use of the chemical within 20 working days if:  

  • the chemical is being introduced for uses other than research and development 

 

Published date
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Keep informed with updates